Contrast Media & Molecular Imaging
Volume 2018 (2018), Article ID 2165693, 2 pages
https://doi.org/10.1155/2018/2165693

Corrigendum

Corrigendum to “Erbium-Based Perfusion Contrast Agent for Small-Animal Microvessel Imaging”

Justin J. Tse,1,2 P. Joy Dunmore-Buyze,¹ Maria Drangova,1,2,3 and David W. Holdsworth1,4

¹Imaging Research Laboratories, Robarts Research Institute, Western University, London, ON, Canada N6A 5B7
²Department of Medical Biophysics, Western University, London, ON, Canada N6A 5C1
³Department of Medical Imaging, Western University, London, ON, Canada N6A 5B7
⁴Department of Surgery, Western University, London, ON, Canada N6A 5B7

Correspondence should be addressed to Justin J. Tse; tse.jjp@gmail.com

Received 19 June 2018; Accepted 2 July 2018; Published 23 August 2018

Copyright © 2018 Justin J. Tse et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Erbium-Based Perfusion Contrast Agent for Small-Animal Microvessel Imaging” [1], there were errors in the scale bars in Figure 3, which should be corrected as follows:

Figure 3: Rebinned 100 μm voxel images where the (a) maximum intensity projection (MIP) of a whole body perfused mouse demonstrates that the attenuation of the Er2O3 contrast agent in the vasculature is higher than the mouse’s skeletal structure. Quantitative measurements of attenuation (in HU) were obtained from regions drawn within heart (b), testes (c), inferior vena cava (d), and cortical bone (e).

References

J. J. Tse, P. J. Dunmore-Buyze, M. Drangova, and D. W. Holdsworth, “Erbium-based perfusion contrast agent for small-animal microvessel imaging,” Contrast Media and Molecular Imaging, vol. 2017, Article ID 7368384, 10 pages, 2017.